Inhibition of miR-455-3p chemosensitizes ESCC cells and reduces the subpopulations of CD90+ and CD271+ T-ICs via the suppression of multiple T-IC-associated pathways, including the Wnt/β-catenin and TGF-β pathways. The gene discussed is THY1; the disease is esophageal squamous cell carcinoma.